Eagle Pharmaceuticals shares owned by Citadel Advisors
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $101k | 27k | 3.73 |
| 2024-03-31 | $276k | 53k | 5.24 |
| 2023-12-31 | $429k | 82k | 5.23 |
| 2023-09-30 | $4.6M | 295k | 15.77 |
| 2023-06-30 | $7.7M | 397k | 19.44 |
| 2023-03-31 | $4.4M | 156k | 28.37 |
| 2022-12-31 | $5.1M | 174k | 29.23 |
| 2022-06-30 | $2.9M | 65k | 44.44 |
| 2022-03-31 | $2.9M | 58k | 49.47 |
| 2021-12-31 | $1.3M | 26k | 50.94 |
| 2021-09-30 | $2.9M | 52k | 55.78 |
| 2021-06-30 | $2.1M | 50k | 42.80 |
| 2021-03-31 | $3.7M | 90k | 41.75 |
| 2020-12-31 | $11M | 235k | 46.57 |
| 2020-09-30 | $14M | 338k | 42.48 |
| 2020-06-30 | $9.4M | 196k | 47.98 |
| 2020-03-31 | $611k | 13k | 45.60 |
| 2019-12-31 | $601k | 10k | 60.07 |
| 2019-09-30 | $3.3M | 58k | 56.55 |
| 2019-06-30 | $3.6M | 64k | 55.63 |
| 2019-03-31 | $4.7M | 93k | 50.48 |
| 2018-12-31 | $1.8M | 45k | 40.31 |
| 2018-09-30 | $24M | 339k | 69.32 |
| 2018-06-30 | $23M | 299k | 75.67 |
| 2018-03-31 | $21M | 397k | 52.69 |
| 2017-12-31 | $5.6M | 105k | 53.44 |
| 2017-09-30 | $1.6M | 28k | 59.64 |
| 2017-06-30 | $3.4M | 43k | 78.89 |
| 2017-03-31 | $4.8M | 58k | 82.83 |
| 2016-12-31 | $11M | 143k | 79.34 |
| 2016-09-30 | $10M | 148k | 70.01 |
| 2016-06-30 | $9.4M | 242k | 38.79 |
| 2016-03-31 | $408k | 10k | 40.48 |
| 2015-12-31 | $2.0M | 22k | 88.69 |
| 2015-09-30 | $370k | 5.0k | 74.03 |
| 2015-03-31 | $268k | 6.4k | 41.86 |